Citation Impact
Citing Papers
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
2007 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Allosteric phenomena in cytochrome P450‐catalyzed monooxygenations
2001
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
1995
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Mechanisms of Thrombus Formation
2008 Standout
Acute and Chronic Endothelial Dysfunction: Implications for the Development of Heart Failure
2003
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
1998
Dynamic PER repression mechanisms in the Drosophila circadian clock: from on-DNA to off-DNA
2010 StandoutNobel
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effects of Beta-Adrenergic Blockade on Survival of Patients With Chronic Heart Failure
1997
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction
2002
Increased myocardial NADPH oxidase activity in human heart failure
2003
Angiotensin–Converting Enzyme Inhibition by Enalapril: A Novel Approach to Reduce Ischemia/Reperfusion Damage After Experimental Liver Transplantation
1997
Uric Acid and Cardiovascular Risk
2008 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Aldosterone-Induced Inflammation in the Rat Heart
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Docking of protein models
2002
Role of oxidative stress in cardiovascular diseases
2000
Molecular Modeling of Cytochrome P450 1A1: Enzyme-Substrate Interactions and Substrate Binding Affinities
2002
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Oxy free radical system in heart failure and therapeutic role of oral vitamin E
1996
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
2004
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure
1997
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
The contribution of thrombosis to the clinical expression of coronary atherosclerosis
1996
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Improved protein structure prediction using potentials from deep learning
2020 StandoutNatureNobel
PatchDock and SymmDock: servers for rigid and symmetric docking
2005 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Antioxidant power of angiotensin‐converting enzyme inhibitors in vitro
1998
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Secondary prevention with folic acid: effects on clinical outcomes
2003
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
2003
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Myocardial Reperfusion Injury
2007 Standout
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
A clockwork web: circadian timing in brain and periphery, in health and disease
2003
Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins
1993
The Role of Oxidative Stress in the Pathogenesis??of COPD
2005
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension
1995
Comparative modelling of cytochromes P450
2002
Expression of p22-phox and gp91-phox, Essential Components of NADPH Oxidase, Increases after Myocardial Infarction
2001
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease
1999
Protein–Protein Docking with Simultaneous Optimization of Rigid-body Displacement and Side-chain Conformations
2003 StandoutNobel
NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease
2001
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Role of oxidants/antioxidants in smoking-induced lung diseases
1996
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
1995
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
2000
A systematic study of low-resolution recognition in protein–protein complexes
1999
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
2006
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks
2002
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
From simple to supramolecular cytochrome P450 mimics
2000
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
2001
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Coronary Plaque Disruption
1995 Standout
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues
2004 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.
1996
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide
1995
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of A. Bridges being referenced
Oxidative Damage in Chronic Heart Failure: Protection by Captopril Through Free Radical Scavenging?
1990
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure
1993
Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease
1990
Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease
1992
Construction of a 3D model of cytochrome P450 2B4
1997
Relationship between the extent of coronary artery disease and indicators of free radical activity
1992
Endothelial dysfunction in acute myocardial infarction after reperfusion
1993
Probucol, a superoxide free radical scavenger in vitro
1991
Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers
1991
Age, sex, cigarette smoking and indices of free radical activity in healthy humans.
1993
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
1993
Oxygen free radicals and congestive heart failure.
1991
Captopril: a free radical scavenger.
1989